Interface Biologics
Toronto, Canada
6 employees
Series B
Total: $32.00M
Biotechnology, Health Care +1
General Information
Get notified when Interface Biologics moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Interface Biologics
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Canada Market
Biotechnology
About Interface Biologics
Taxonomy: biomedical polymer technology, anti-thrombogenic additives, thrombosis reduction, drug delivery devices
Funding Rounds & Investors (6)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series B | •••••• | 2 |
|
13 Jan 2015 |
| Venture Round | •••••• | - | 08 Dec 2011 | |
| Series B | •••••• | 2 | •••• •••• | 11 Jan 2011 |
| Series A | •••••• | - | 01 Jan 2010 | |
| Venture Round | •••••• | 2 |
|
09 Dec 2008 |
Interface Biologics Alternatives & Competitors
We apply bacteria-phobic coatings to medical devices, to tackle one of the major causes of hospital...
Improving the lives of patients by enabling medical devices with Elast-Eon, the world's leading impl...
AQTIS Medical focuses on the innovation, production, and distribution of medical devices designed fo...
FAQ About Interface Biologics
Don't just browse. Track.
Signal Tracker monitors Interface Biologics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.
